Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-02-23
1986-03-18
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546157, A61K 3147, C07D21522
Patent
active
045769532
ABSTRACT:
Compounds of the formula: ##STR1## wherein X stands for an oxygen or sulphur atom, n stands for 1 or 2, R.sup.1 stands for a defined (3-4C)alkyl radical, a cyclopropyl radical, or a phenyl radical which may optionally bear a halogeno, (1-4C)alkyl or (1-4C)alkoxy substituent, and R.sup.2 stands for hydrogen or a (1-4C)alkyl radical, and pharmaceutically-acceptable acid-addition salts thereof. Process for the manufacture of said compounds. Pharmaceutical compositions comprising one of said compounds and a pharmaceutical diluent or carrier. The compounds are peripherally selective 5-HT antagonists.
REFERENCES:
patent: 1572768 (1926-02-01), Callsen
patent: 4435405 (1984-03-01), Blackburn
March, "Advanced Organic Chemistry", 2nd Edition, p. 819.
Benson Robert
Daus Donald G.
Imperial Chemical Industries plc
LandOfFree
Quinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2306354